propranolol has been researched along with Dermatitis Medicamentosa in 19 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Excerpt | Relevance | Reference |
---|---|---|
"Sclerosing peritonitis developed in a 43-year-old man with angina pectoris who had been receiving the beta-adrenergic receptor antagonist, propranolol." | 7.66 | Sclerosing peritonitis and propranolol. ( Harty, RF, 1978) |
"Propranolol, 0." | 5.29 | Psoriasis-like lesions in guinea pigs receiving propranolol. ( Altug, T; Büyükdevrim, S; Gürel, N; Tüzün, B; Tüzün, Y; Tüzüner, N, 1993) |
"Dermal application of propranolol (PRL) induced formation of erythema and edema, and pseudoeosinophil infiltration in epidermis and dermis at the application site in guinea pigs." | 3.70 | Role of prostaglandin E2 and leukotriene B4 in skin reaction induced by transdermal application of propranolol. ( Gemba, M; Hosaka, K; Kamiyama, M; Kobayashi, I; Konno, C; Maruo, H; Saeki, Y, 2000) |
"Sclerosing peritonitis developed in a 43-year-old man with angina pectoris who had been receiving the beta-adrenergic receptor antagonist, propranolol." | 3.66 | Sclerosing peritonitis and propranolol. ( Harty, RF, 1978) |
" In general, it was considered that the duration and the extent of these reactions were dependent on the PRL dosage and application time." | 1.30 | Relationship between the skin permeation movement of propranolol and skin inflammatory reactions. ( Gemba, M; Hosaka, K; Kamiyama, M; Kobayashi, I; Konno, C; Maruo, H; Saeki, Y, 1998) |
"Propranolol, 0." | 1.29 | Psoriasis-like lesions in guinea pigs receiving propranolol. ( Altug, T; Büyükdevrim, S; Gürel, N; Tüzün, B; Tüzün, Y; Tüzüner, N, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (68.42) | 18.7374 |
1990's | 4 (21.05) | 18.2507 |
2000's | 2 (10.53) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zaccaria, E | 1 |
Gualco, F | 1 |
Drago, F | 1 |
Rebora, A | 1 |
Sillevis Smitt, JH | 2 |
van Joost, T | 2 |
Oliver, R | 1 |
Nicholls, JT | 1 |
Rutty, DA | 1 |
Halevy, S | 2 |
Livni, E | 1 |
Tüzün, B | 1 |
Tüzün, Y | 1 |
Gürel, N | 1 |
Tüzüner, N | 1 |
Altug, T | 1 |
Büyükdevrim, S | 1 |
Kobayashi, I | 2 |
Hosaka, K | 2 |
Maruo, H | 2 |
Saeki, Y | 2 |
Kamiyama, M | 2 |
Konno, C | 2 |
Gemba, M | 2 |
Frishman, W | 1 |
Silverman, R | 1 |
Strom, J | 1 |
Elkayam, U | 1 |
Sonnenblick, E | 1 |
Faure, M | 1 |
Hermier, C | 1 |
Perrot, H | 1 |
Jensen, HA | 1 |
Mikkelsen, HI | 1 |
Wadskov, S | 1 |
Sondergaard, J | 1 |
Enger, E | 1 |
van Ketel, WG | 1 |
Soesman-van Waadenoyen Kernekamp, A | 1 |
Harty, RF | 1 |
Gokal, R | 1 |
Dornan, TL | 1 |
Ledingham, JG | 1 |
Feuerman, EJ | 1 |
Massa, MC | 1 |
Jason, SM | 1 |
Gradini, R | 1 |
Welykyj, S | 1 |
Stephen, SA | 1 |
19 other studies available for propranolol and Dermatitis Medicamentosa
Article | Year |
---|---|
Fixed drug eruption due to propranolol.
Topics: Antihypertensive Agents; Drug Eruptions; Female; Humans; Middle Aged; Propranolol | 2006 |
[Beta-adrenoreceptor blocking drugs and epicutaneous allergologic studies].
Topics: Adrenergic beta-Antagonists; Cross Reactions; Drug Eruptions; Female; Humans; Middle Aged; Propranol | 1981 |
Skin reactions to propranolol and cross sensitivity to beta-adrenoreceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Cross Reactions; Drug Eruptions; Female; Humans; Middle Aged; Patch Tes | 1981 |
The drug eruption story.
Topics: Drug Eruptions; Humans; Propranolol; Sulfones; Urticaria | 1983 |
Sclerosing peritonitis with short-term propranolol therapy.
Topics: Drug Eruptions; Eye Diseases; Humans; Peritonitis; Propranolol; Sclerosis | 1980 |
Beta-adrenergic blocking drugs and psoriasis: the role of an immunologic mechanism.
Topics: Cell Migration Inhibition; Drug Eruptions; Humans; Propranolol; Psoriasis | 1993 |
Psoriasis-like lesions in guinea pigs receiving propranolol.
Topics: Acanthosis Nigricans; Administration, Cutaneous; Animals; Drug Eruptions; Female; Guinea Pigs; Male; | 1993 |
Relationship between the skin permeation movement of propranolol and skin inflammatory reactions.
Topics: Adrenergic beta-Antagonists; Animals; Capillary Permeability; Drug Eruptions; Erythema; Guinea Pigs; | 1998 |
Role of prostaglandin E2 and leukotriene B4 in skin reaction induced by transdermal application of propranolol.
Topics: Administration, Cutaneous; Administration, Topical; Adrenergic beta-Antagonists; Animals; Anti-Infla | 2000 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bronchi; Central Nervous System Diseases; Deafnes | 1979 |
[Cutaneous reactions to propranolol (author's transl)].
Topics: Adolescent; Adrenergic beta-Antagonists; Antibodies, Antinuclear; Drug Eruptions; Eczema; Humans; Lu | 1979 |
Cutaneous reactions to propranolol (Inderal).
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Drug Eruptions; Female; Humans; Hypertension; Male; Mid | 1976 |
[Letter: Propranolol--psoriasiform eruption].
Topics: Drug Eruptions; Humans; Hypertension; Male; Middle Aged; Propranolol; Psoriasis | 1976 |
[A propranolol dermatitis mimicking Lyell's syndrome].
Topics: Drug Eruptions; Humans; Hypertension; Male; Middle Aged; Propranolol; Stevens-Johnson Syndrome | 1977 |
Sclerosing peritonitis and propranolol.
Topics: Adult; Conjunctivitis; Drug Eruptions; Humans; Male; Peritonitis; Propranolol; Sclerosis | 1978 |
Peripheral skin necrosis complicating beta-blockage.
Topics: Aged; Atenolol; Drug Eruptions; Female; Foot; Foot Dermatoses; Humans; Ischemia; Male; Middle Aged; | 1979 |
Psoriasiform eruption induced by propranolol.
Topics: Aged; Arrhythmias, Cardiac; Complement C3; Drug Eruptions; Fibrinogen; Humans; Immunoglobulin M; Mac | 1979 |
Lichenoid drug eruption secondary to propranolol.
Topics: Aged; Drug Eruptions; Humans; Keratosis; Lichen Planus; Male; Necrosis; Penile Diseases; Propranolol | 1991 |
Unwanted effects of propranolol.
Topics: Blood Cell Count; Blood Urea Nitrogen; Bradycardia; Drug Eruptions; Enzymes; Heart Failure; Humans; | 1966 |